AFLIBERCEPT

AFLIBERCEPT was reported 31420 times

AFLIBERCEPT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NON-INFECTIOUS ENDOPHTHALMITIS 464 0.5465
1 LENS CAPSULOTOMY 7 0.5385
2 INTRA-OCULAR INJECTION COMPLICATION 113 0.4978
3 VITRECTOMY 275 0.4614
4 VITREAL CELLS 81 0.4010
5 IRIS VASCULAR DISORDER 6 0.4000
6 SUBRETINAL HYPERREFLECTIVE EXUDATION 10 0.3704
7 POLYPOIDAL CHOROIDAL VASCULOPATHY 107 0.3452
8 NONINFECTIVE RETINITIS 8 0.3333
9 INTRA-OCULAR INJECTION 17 0.3208
10 VITREOUS HAZE 49 0.3203
11 RETINAL FIBROSIS 20 0.2778
12 ANTERIOR CHAMBER FLARE 62 0.2661
13 VISUAL ACUITY REDUCED TRANSIENTLY 81 0.2630
14 RETINAL LASER COAGULATION 7 0.2593
15 VITRITIS 479 0.2585
16 SUBRETINAL FLUID 281 0.2571
17 EYE INFECTION INTRAOCULAR 20 0.2564
18 ANTERIOR CHAMBER CELL 179 0.2507
19 MACULAR THICKENING 21 0.2500
20 VITREOUS FIBRIN 7 0.2500
21 RETINAL OCCLUSIVE VASCULITIS 55 0.2455
22 ENDOPHTHALMITIS 1431 0.2383
23 BACTERIAL ENDOPHTHALMITIS 61 0.2293
24 VITREOUS OPACITIES 191 0.2260
25 CORNEAL STRIAE 15 0.2113
26 ANTERIOR CHAMBER INFLAMMATION 122 0.2050
27 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 274 0.1960
28 PSEUDOENDOPHTHALMITIS 19 0.1919
29 VITREOUS DISORDER 91 0.1884
30 DIAPHRAGMATIC OPERATION 6 0.1818
31 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 13 0.1781
32 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 152 0.1708
33 DIABETIC RETINAL OEDEMA 86 0.1693
34 MACULAR RUPTURE 6 0.1667
35 OCULAR PROCEDURAL COMPLICATION 32 0.1649
36 ANTERIOR CHAMBER DISORDER 37 0.1609
37 EYE COMPLICATION ASSOCIATED WITH DEVICE 43 0.1599
38 KERATIC PRECIPITATES 75 0.1579
39 RETINAL PIGMENT EPITHELIAL TEAR 100 0.1441
40 RETINAL OEDEMA 273 0.1426
41 BLINDNESS TRANSIENT 1048 0.1420
42 POSTERIOR CAPSULE RUPTURE 11 0.1392
43 HYPOPYON 113 0.1365
44 OCULAR VASCULITIS 23 0.1329
45 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 48 0.1322
46 MACULAR SCAR 24 0.1237
47 EYE LASER SURGERY 72 0.1218
48 HYPOTONY OF EYE 51 0.1214
49 DETACHMENT OF MACULAR RETINAL PIGMENT EPITHELIUM 6 0.1154
50 EPIRETINAL MEMBRANE 32 0.1151
51 EYE INFECTION STAPHYLOCOCCAL 32 0.1107
52 RETINAL SCAR 50 0.1085
53 RETINAL NEOVASCULARISATION 27 0.1071
54 EYE INFLAMMATION 1021 0.1069
55 RETINAL PERIVASCULAR SHEATHING 11 0.1068
56 MACULAR HOLE 142 0.1057
57 INTRAOCULAR PRESSURE DECREASED 55 0.1044
58 CHOROIDAL NEOVASCULARISATION 89 0.1037
59 PSEUDOPHAKIA 9 0.1034
60 RETINAL CYST 17 0.1024
61 VITREOUS HAEMORRHAGE 278 0.1005
62 DRY AGE-RELATED MACULAR DEGENERATION 108 0.0973
63 RHEGMATOGENOUS RETINAL DETACHMENT 20 0.0957
64 OCULAR ISCHAEMIC SYNDROME 8 0.0941
65 AGE-RELATED MACULAR DEGENERATION 139 0.0915
66 RETINAL VASCULITIS 108 0.0907
67 INTRAOCULAR LENS IMPLANT 44 0.0889
68 RETINAL HAEMORRHAGE 614 0.0861
69 VITREOUS FLOATERS 842 0.0856
70 METAMORPHOPSIA 152 0.0824
71 PANOPHTHALMITIS 15 0.0820
72 RETINAL DEPIGMENTATION 25 0.0817
73 RETINAL DRUSEN 13 0.0793
74 BLINDNESS UNILATERAL 1103 0.0781
75 MACULAR FIBROSIS 52 0.0767
76 SUDDEN VISUAL LOSS 21 0.0753
77 VITREORETINAL TRACTION SYNDROME 7 0.0737
78 CENTRAL VISION LOSS 16 0.0717
79 VITREOUS ADHESIONS 8 0.0696
80 RETINAL VASCULAR DISORDER 40 0.0684
81 VITREOUS DEGENERATION 11 0.0671
82 SUBRETINAL FIBROSIS 13 0.0667
83 RETINAL EXUDATES 62 0.0662
84 EYE INFECTION BACTERIAL 36 0.0645
85 RETINAL ARTERY OCCLUSION 161 0.0637
86 TRACTIONAL RETINAL DETACHMENT 7 0.0631
87 CORNEAL ENDOTHELIITIS 6 0.0625
88 RETINAL THICKENING 104 0.0623
89 LASER THERAPY 14 0.0622
90 EYE HAEMORRHAGE 827 0.0619
91 INTRAOCULAR PRESSURE INCREASED 787 0.0615
92 RETINAL OPERATION 17 0.0609
93 RETINAL ISCHAEMIA 37 0.0606
94 OPTICAL COHERENCE TOMOGRAPHY ABNORMAL 52 0.0605
95 RETINAL ANEURYSM 12 0.0600
96 OCULAR HYPERTENSION 115 0.0592
97 RETINAL DEPOSITS 12 0.0591
98 TOXIC ANTERIOR SEGMENT SYNDROME 64 0.0587
99 RETINAL VASCULAR OCCLUSION 43 0.0581
100 RETINOSCHISIS 8 0.0580
101 RETINAL DEGENERATION 73 0.0562
102 IRIS NEOVASCULARISATION 7 0.0560
103 POSTERIOR CAPSULE OPACIFICATION 19 0.0554
104 IRIDOCYCLITIS 172 0.0544
105 ANTERIOR CHAMBER FIBRIN 7 0.0543
106 DRUG-DEVICE INTERACTION 6 0.0541
107 CHOROIDAL HAEMORRHAGE 10 0.0518
108 INTRAOCULAR PRESSURE FLUCTUATION 10 0.0508
109 VISUAL ACUITY TESTS ABNORMAL 28 0.0504
110 MACULAR OEDEMA 267 0.0476
111 IRITIS 144 0.0473
112 CORNEAL OEDEMA 103 0.0459
113 TACHYPHYLAXIS 16 0.0458
114 LENS DISORDER 13 0.0451
115 CHORIORETINITIS 29 0.0450
116 DEPOSIT EYE 12 0.0448
117 CHOROIDAL DETACHMENT 24 0.0432
118 LENS DISLOCATION 9 0.0429
119 HYPHAEMA 22 0.0421
120 AMAUROSIS FUGAX 45 0.0418
121 IDIOPATHIC ORBITAL INFLAMMATION 8 0.0417
122 CONJUNCTIVAL SCAR 6 0.0397
123 VISUAL ACUITY REDUCED 1309 0.0394
124 GLAUCOMA SURGERY 10 0.0391
125 EYE EXCISION 8 0.0390
126 ADENOCARCINOMA METASTATIC 8 0.0388
127 RETINAL VEIN OCCLUSION 110 0.0382
128 CATARACT OPERATION 225 0.0379
129 BLINDNESS 1507 0.0369
130 FOREIGN BODY IN EYE 35 0.0365
131 VITREOUS DETACHMENT 78 0.0360
132 RETINOPATHY PROLIFERATIVE 7 0.0359
133 CORNEAL ABRASION 48 0.0350
134 PROTEUS INFECTION 25 0.0348
135 RETINAL PIGMENT EPITHELIOPATHY 15 0.0347
136 SCLERAL HAEMORRHAGE 8 0.0346
137 CONJUNCTIVAL DISORDER 13 0.0341
138 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 6 0.0339
139 CHORIORETINAL ATROPHY 7 0.0338
140 UVEITIS 458 0.0337
141 FLAT ANTERIOR CHAMBER OF EYE 6 0.0335
142 SCLERAL DISORDER 9 0.0333
143 MACULAR DETACHMENT 8 0.0331
144 PRODUCT IMPURITY 9 0.0328
145 SEROUS RETINAL DETACHMENT 27 0.0322
146 CARDIOMYOPATHY ACUTE 7 0.0320
147 EYE OEDEMA 77 0.0314
148 DYSCHROMATOPSIA 26 0.0314
149 PHARYNGOTONSILLITIS 7 0.0311
150 AMAUROSIS 26 0.0309
151 GLARE 15 0.0292
152 CATARACT NUCLEAR 19 0.0285
153 RETINAL DISORDER 73 0.0280
154 LENTICULAR OPACITIES 12 0.0275
155 NEOVASCULARISATION 7 0.0266
156 THROMBOTIC CEREBRAL INFARCTION 10 0.0265
157 OPTIC DISC HAEMORRHAGE 6 0.0262
158 RETINAL DETACHMENT 240 0.0261
159 PTERYGIUM 9 0.0260
160 RETINAL INJURY 20 0.0259
161 CONJUNCTIVAL HAEMORRHAGE 97 0.0254
162 PATIENT UNCOOPERATIVE 12 0.0253
163 EYE OPERATION 115 0.0249
164 CYSTOID MACULAR OEDEMA 47 0.0249
165 CORNEAL DEPOSITS 18 0.0242
166 EYE INFECTION 267 0.0236
167 IRIS ADHESIONS 12 0.0234
168 REFUSAL OF TREATMENT BY PATIENT 152 0.0233
169 EYE HAEMATOMA 6 0.0228
170 EYE PAIN 1242 0.0220
171 EYE INJURY 66 0.0217
172 MULTIPLE USE OF SINGLE-USE PRODUCT 119 0.0212
173 OPEN ANGLE GLAUCOMA 13 0.0212
174 FOREIGN BODY SENSATION IN EYES 135 0.0212
175 INJURY CORNEAL 11 0.0212
176 COLORECTAL CANCER METASTATIC 50 0.0211
177 BINOCULAR EYE MOVEMENT DISORDER 6 0.0208
178 PROTHROMBIN LEVEL DECREASED 19 0.0202
179 RETINAL VASCULAR THROMBOSIS 10 0.0190
180 CENTRAL SEROUS CHORIORETINOPATHY 13 0.0190
181 CHOROIDAL EFFUSION 15 0.0187
182 CORNEAL EROSION 10 0.0186
183 OCULAR DISCOMFORT 204 0.0182
184 CATARACT SUBCAPSULAR 11 0.0180
185 SUSPECTED PRODUCT QUALITY ISSUE 33 0.0180
186 VISUAL FIELD DEFECT 130 0.0180
187 RETINAL TEAR 44 0.0178
188 CATARACT OPERATION COMPLICATION 9 0.0177
189 SUPERFICIAL INJURY OF EYE 19 0.0174
190 VISUAL IMPAIRMENT 2151 0.0173
191 CORNEAL DISORDER 38 0.0173
192 INTRAOCULAR PRESSURE TEST ABNORMAL 12 0.0170
193 OCULAR VASCULAR DISORDER 14 0.0170
194 CORNEAL OPACITY 22 0.0161
195 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 20 0.0161
196 PHOTOPSIA 96 0.0152
197 DIABETIC RETINOPATHY 51 0.0150
198 CORNEAL DYSTROPHY 6 0.0144
199 RETINAL VEIN THROMBOSIS 10 0.0143
200 INTRAVASCULAR HAEMOLYSIS 8 0.0143
201 NECROTISING RETINITIS 9 0.0141
202 CORNEAL SCAR 7 0.0139
203 OPTIC NERVE INJURY 16 0.0138
204 CORNEAL EPITHELIUM DEFECT 8 0.0138
205 TRAUMATIC FRACTURE 10 0.0136
206 HYPOAESTHESIA EYE 8 0.0136
207 MACULAR DEGENERATION 161 0.0135
208 SCLERITIS 21 0.0131
209 PUNCTATE KERATITIS 12 0.0131
210 ABNORMAL SENSATION IN EYE 55 0.0128
211 PUNCTURE SITE HAEMORRHAGE 9 0.0127
212 CHROMATOPSIA 9 0.0119
213 PUPILLARY DISORDER 7 0.0115
214 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 6 0.0115
215 PHOTOPHOBIA 208 0.0110
216 DYSLALIA 8 0.0110
217 ALTERED VISUAL DEPTH PERCEPTION 9 0.0110
218 MACULOPATHY 39 0.0110
219 SICKLE CELL ANAEMIA 7 0.0109
220 EYE DISORDER 357 0.0108
221 EYE DISCHARGE 112 0.0108
222 CONJUNCTIVAL OEDEMA 11 0.0107
223 INDURATION 19 0.0107
224 DEVICE USE ISSUE 183 0.0105
225 PROCEDURAL ANXIETY 7 0.0103
226 EYE BURNS 6 0.0102
227 KERATITIS 30 0.0099
228 RETINITIS 17 0.0098
229 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 9 0.0097
230 GLAUCOMA 187 0.0097
231 CATARACT 575 0.0096
232 ADENOCARCINOMA OF COLON 18 0.0096
233 COLITIS MICROSCOPIC 45 0.0095
234 ULCERATIVE KERATITIS 26 0.0095
235 CHALAZION 6 0.0094
236 LACRIMATION INCREASED 281 0.0093
237 DEATH 7883 0.0091
238 VISION BLURRED 1245 0.0091
239 EMBOLIC CEREBRAL INFARCTION 6 0.0090
240 VENA CAVA THROMBOSIS 15 0.0090
241 ANGLE CLOSURE GLAUCOMA 23 0.0090
242 OCULAR HYPERAEMIA 421 0.0089
243 ANASTOMOTIC LEAK 6 0.0086
244 CLEAR CELL RENAL CELL CARCINOMA 6 0.0086
245 CONJUNCTIVAL HYPERAEMIA 30 0.0084
246 OPTIC NERVE DISORDER 13 0.0081
247 NIGHT BLINDNESS 13 0.0081
248 THALAMUS HAEMORRHAGE 7 0.0080
249 BLEPHARITIS 32 0.0080
250 INJECTION SITE DISCOMFORT 83 0.0079
251 EYE COLOUR CHANGE 8 0.0079
252 CORNEAL TRANSPLANT 6 0.0077
253 ADENOCARCINOMA 17 0.0076
254 IIIRD NERVE PARALYSIS 6 0.0074
255 CLOSTRIDIAL INFECTION 25 0.0074
256 RECTAL TENESMUS 9 0.0072
257 GIANT CELL ARTERITIS 6 0.0072
258 STOMA SITE HAEMORRHAGE 11 0.0071
259 PERIODONTAL DISEASE 10 0.0071
260 ASTHENOPIA 39 0.0071
261 HALO VISION 8 0.0071
262 PRODUCT CONTAMINATION 25 0.0070
263 SUSPECTED PRODUCT CONTAMINATION 7 0.0069
264 HERPES OPHTHALMIC 9 0.0068
265 NECROTISING FASCIITIS 24 0.0068
266 OPTIC ATROPHY 11 0.0067
267 INJECTION RELATED REACTION 11 0.0067
268 EYE CONTUSION 14 0.0066
269 COLOUR BLINDNESS 6 0.0065
270 RENAL ATROPHY 8 0.0064
271 EYELID PAIN 13 0.0064
272 OCULAR TOXICITY 7 0.0063
273 DIABETIC COMPLICATION 16 0.0063
274 INJURY ASSOCIATED WITH DEVICE 127 0.0062
275 INTENTIONAL DOSE OMISSION 177 0.0062
276 MULTIPLE-DRUG RESISTANCE 19 0.0061
277 COLON ADENOMA 6 0.0061
278 DRUG EFFECT LESS THAN EXPECTED 90 0.0061
279 EYELID DISORDER 14 0.0061
280 SYRINGE ISSUE 105 0.0060
281 EMBOLISM ARTERIAL 7 0.0058
282 PHARYNGEAL INFLAMMATION 7 0.0058
283 KLEBSIELLA INFECTION 29 0.0057
284 PROTEINURIA 107 0.0056
285 OPHTHALMIC HERPES ZOSTER 10 0.0055
286 EYE IRRITATION 316 0.0055
287 FEAR OF INJECTION 39 0.0055
288 SWELLING OF EYELID 33 0.0053
289 STAPHYLOCOCCUS TEST POSITIVE 11 0.0052
290 EYE ALLERGY 8 0.0052
291 HORDEOLUM 22 0.0051
292 DIABETIC METABOLIC DECOMPENSATION 7 0.0050
293 SKIN TOXICITY 28 0.0049
294 EYE SWELLING 178 0.0048
295 NEPHROTIC SYNDROME 30 0.0044
296 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7 0.0044
297 CEREBRAL INFARCTION 106 0.0043
298 OPTIC NEUROPATHY 9 0.0042
299 CHORIORETINOPATHY 6 0.0042
300 CEREBELLAR HAEMORRHAGE 6 0.0042
301 THERAPEUTIC PRODUCT INEFFECTIVE 16 0.0041
302 BLOOD LACTIC ACID INCREASED 21 0.0040
303 SUDDEN HEARING LOSS 8 0.0040
304 IMMUNE-MEDIATED ADVERSE REACTION 6 0.0039
305 PRODUCT DOSE OMISSION ISSUE 1139 0.0039
306 HYPERTENSIVE CRISIS 42 0.0038
307 PAPILLOEDEMA 17 0.0038
308 CAROTID ARTERY STENOSIS 13 0.0037
309 SLOW SPEECH 9 0.0037
310 PERIODONTITIS 8 0.0037
311 NEUTROPHILIA 21 0.0037
312 OPTIC ISCHAEMIC NEUROPATHY 14 0.0036
313 RETINOPATHY 13 0.0035
314 INJECTION SITE INFLAMMATION 17 0.0034
315 HEMIPLEGIA 28 0.0034
316 VASCULAR OCCLUSION 7 0.0033
317 RECTAL CANCER 10 0.0033
318 STREPTOCOCCAL INFECTION 18 0.0032
319 SUDDEN DEATH 34 0.0032
320 DIABETIC NEPHROPATHY 7 0.0032
321 INTERCEPTED PRODUCT PREPARATION ERROR 39 0.0032
322 EMBOLIC STROKE 11 0.0031
323 PRODUCT DOSE OMISSION 203 0.0031
324 VENTRICULAR DYSFUNCTION 8 0.0031
325 CYTOMEGALOVIRUS CHORIORETINITIS 6 0.0031
326 INFARCTION 21 0.0031
327 CONJUNCTIVITIS 56 0.0030
328 HYPOACUSIS 129 0.0030
329 IMPAIRED DRIVING ABILITY 34 0.0030
330 INVASIVE DUCTAL BREAST CARCINOMA 8 0.0029
331 TRANSIENT ISCHAEMIC ATTACK 99 0.0029
332 LACUNAR INFARCTION 7 0.0029
333 ACUTE CORONARY SYNDROME 24 0.0029
334 VIITH NERVE PARALYSIS 10 0.0029
335 EYELIDS PRURITUS 9 0.0029
336 DRY EYE 144 0.0029
337 INCORRECT DOSAGE ADMINISTERED 14 0.0029
338 ANGIOPATHY 16 0.0029
339 PROCTALGIA 18 0.0028
340 METASTASES TO PERITONEUM 7 0.0028
341 MONOPLEGIA 12 0.0028
342 PULMONARY FUNCTION TEST DECREASED 12 0.0027
343 GASTROINTESTINAL TOXICITY 13 0.0027
344 HICCUPS 22 0.0027
345 NEUTROPENIC SEPSIS 19 0.0027
346 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25 0.0026
347 ISCHAEMIA 12 0.0026
348 ANAESTHETIC COMPLICATION 7 0.0026
349 MIGRAINE WITH AURA 7 0.0026
350 PERIPHERAL SENSORY NEUROPATHY 15 0.0026
351 MUCOSAL INFLAMMATION 66 0.0025
352 MYOPIA 6 0.0025
353 METASTASES TO LUNG 29 0.0025
354 PROCEDURAL COMPLICATION 19 0.0025
355 ANGINA UNSTABLE 16 0.0025
356 EYE PRURITUS 82 0.0024
357 VASCULAR GRAFT 7 0.0024
358 DISEASE PROGRESSION 286 0.0024
359 RHINITIS 19 0.0024
360 FACIAL PAIN 21 0.0024
361 HOSPITALISATION 361 0.0023
362 PURULENT DISCHARGE 10 0.0023
363 BLOOD CHLORIDE DECREASED 6 0.0023
364 INTESTINAL PERFORATION 26 0.0023
365 FUNCTIONAL GASTROINTESTINAL DISORDER 8 0.0023
366 FIBROSIS 7 0.0023
367 CARDIAC OPERATION 19 0.0022
368 CEREBRAL HAEMORRHAGE 79 0.0022
369 CEREBROVASCULAR ACCIDENT 366 0.0022
370 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 63 0.0021
371 EYELID OEDEMA 25 0.0021
372 PRODUCT TEMPERATURE EXCURSION ISSUE 11 0.0021
373 CEREBRAL ISCHAEMIA 11 0.0021
374 ISCHAEMIC STROKE 38 0.0021
375 CHOLECYSTITIS ACUTE 12 0.0021
376 DEMENTIA 59 0.0021
377 TENDERNESS 22 0.0021
378 CEREBRAL HAEMATOMA 7 0.0021
379 LUNG CANCER METASTATIC 6 0.0021
380 HAEMORRHAGIC STROKE 16 0.0020
381 PARONYCHIA 9 0.0020
382 DIPLOPIA 53 0.0020
383 ARTERIAL OCCLUSIVE DISEASE 16 0.0020
384 INFLAMMATION 105 0.0020
385 LEFT VENTRICULAR FAILURE 7 0.0020
386 PRODUCT PRESCRIBING ISSUE 44 0.0020
387 LARGE INTESTINE PERFORATION 14 0.0020
388 AZOTAEMIA 8 0.0020
389 SUSPECTED OFF LABEL USE 9 0.0020
390 INTRACRANIAL ANEURYSM 8 0.0020
391 CEREBROVASCULAR DISORDER 6 0.0020
392 POST PROCEDURAL COMPLICATION 38 0.0020
393 DIALYSIS 28 0.0020
394 CANDIDA INFECTION 33 0.0020
395 PHLEBITIS 10 0.0020
396 CONCOMITANT DISEASE AGGRAVATED 12 0.0019
397 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 138 0.0019
398 RENAL TRANSPLANT 7 0.0019
399 PRODUCT USE ISSUE 364 0.0019
400 OFF LABEL USE 1686 0.0019
401 NON-CARDIAC CHEST PAIN 6 0.0019
402 CEREBRAL DISORDER 14 0.0019
403 ENTEROCOCCAL INFECTION 9 0.0019
404 HYPERTENSION 394 0.0019
405 BLOOD PRESSURE INADEQUATELY CONTROLLED 11 0.0018
406 NEUROTOXICITY 32 0.0018
407 DERMATITIS ACNEIFORM 11 0.0018
408 INJECTION SITE INJURY 10 0.0018
409 COAGULOPATHY 30 0.0018
410 PROCEDURAL HAEMORRHAGE 7 0.0018
411 COLITIS ISCHAEMIC 12 0.0018
412 FACIAL PARALYSIS 15 0.0018
413 UNEVALUABLE EVENT 133 0.0018
414 AUTOIMMUNE HAEMOLYTIC ANAEMIA 6 0.0017
415 PRODUCT ADMINISTRATION ERROR 35 0.0017
416 PERIPHERAL ISCHAEMIA 7 0.0017
417 LEG AMPUTATION 7 0.0017
418 EMBOLISM 14 0.0017
419 INTERCEPTED PRODUCT STORAGE ERROR 6 0.0017
420 THERAPEUTIC PRODUCT EFFECT DECREASED 75 0.0017
421 SUBARACHNOID HAEMORRHAGE 17 0.0017
422 FACIAL BONES FRACTURE 6 0.0017
423 ERYTHEMA OF EYELID 9 0.0017
424 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 298 0.0017
425 METASTASES TO LIVER 29 0.0016
426 CARDIAC FAILURE CHRONIC 7 0.0016
427 DEAFNESS UNILATERAL 9 0.0016
428 THERAPEUTIC RESPONSE DECREASED 99 0.0016
429 NEUTROPENIA 221 0.0016
430 METASTATIC NEOPLASM 7 0.0016
431 CHOLANGITIS 10 0.0016
432 ACUTE PULMONARY OEDEMA 9 0.0016
433 CORONARY ARTERY STENOSIS 8 0.0016
434 CHEMOTHERAPY 6 0.0016
435 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 27 0.0016
436 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 314 0.0015
437 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 36 0.0015
438 HYPOALBUMINAEMIA 12 0.0015
439 PELVIC FRACTURE 12 0.0015
440 ACUTE MYOCARDIAL INFARCTION 45 0.0015
441 HOSPICE CARE 15 0.0015
442 RASH PUSTULAR 11 0.0015
443 CARDIAC PACEMAKER INSERTION 9 0.0015
444 ODYNOPHAGIA 9 0.0015
445 ORGAN FAILURE 6 0.0015
446 PULMONARY THROMBOSIS 16 0.0015
447 HYPOVOLAEMIC SHOCK 7 0.0015
448 STOMATITIS 88 0.0014
449 HYPERTHERMIA 11 0.0014
450 EOSINOPHIL COUNT INCREASED 12 0.0014
451 LEUKOCYTOSIS 26 0.0014
452 MYOCARDIAL INFARCTION 248 0.0014
453 POLYNEUROPATHY 17 0.0014
454 PERIORBITAL SWELLING 8 0.0014
455 INFLAMMATORY MARKER INCREASED 7 0.0014
456 GENERAL PHYSICAL HEALTH DETERIORATION 163 0.0014
457 NEEDLE ISSUE 41 0.0014
458 ERYSIPELAS 7 0.0014
459 EYELID PTOSIS 14 0.0014
460 MELANOCYTIC NAEVUS 6 0.0014
461 HIP FRACTURE 44 0.0014
462 STENT PLACEMENT 11 0.0014
463 DRUG RESISTANCE 35 0.0014
464 PERIPHERAL VASCULAR DISORDER 7 0.0014
465 ABDOMINAL ABSCESS 6 0.0014
466 DIABETES MELLITUS INADEQUATE CONTROL 24 0.0014
467 VARICOSE VEIN 7 0.0014
468 HYPERBILIRUBINAEMIA 14 0.0014
469 ILL-DEFINED DISORDER 82 0.0013
470 ANGINA PECTORIS 38 0.0013
471 EYE MOVEMENT DISORDER 9 0.0013
472 TROPONIN INCREASED 10 0.0013
473 IMMUNE THROMBOCYTOPENIA 6 0.0013
474 DRUG DOSE OMISSION 213 0.0013
475 ILEUS 16 0.0013
476 ENTERITIS 8 0.0012
477 MYDRIASIS 16 0.0012
478 HEMIPARESIS 21 0.0012
479 POLYP 8 0.0012
480 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 67 0.0012
481 PULMONARY EMBOLISM 116 0.0012
482 PRODUCT PREPARATION ISSUE 8 0.0012
483 BODY HEIGHT DECREASED 13 0.0012
484 NEOPLASM MALIGNANT 81 0.0012
485 ADVERSE REACTION 16 0.0012
486 HYDRONEPHROSIS 9 0.0012
487 SURGERY 70 0.0012
488 WRONG PRODUCT ADMINISTERED 8 0.0012
489 CORONARY ARTERIAL STENT INSERTION 6 0.0012
490 CARDIAC FAILURE 95 0.0012
491 OSTEONECROSIS OF JAW 29 0.0012
492 INJECTION SITE PAIN 359 0.0012
493 CORONARY ARTERY OCCLUSION 16 0.0012
494 ATRIOVENTRICULAR BLOCK 9 0.0012
495 METASTASES TO CENTRAL NERVOUS SYSTEM 15 0.0012
496 LARGE INTESTINE POLYP 8 0.0012
497 PULMONARY HAEMORRHAGE 9 0.0011
498 MYOCARDIAL ISCHAEMIA 13 0.0011
499 THROMBOTIC MICROANGIOPATHY 11 0.0011
500 ATRIAL FLUTTER 9 0.0011
501 ANAL ABSCESS 6 0.0011
502 DEAFNESS 29 0.0011
503 RHINORRHOEA 71 0.0011
504 OESOPHAGITIS 12 0.0011
505 EPISTAXIS 82 0.0011
506 THERAPY PARTIAL RESPONDER 17 0.0011
507 SINUS DISORDER 21 0.0011
508 DERMATITIS CONTACT 12 0.0011
509 AORTIC ANEURYSM 8 0.0011
510 SCAR 18 0.0011
511 CARDIAC FAILURE ACUTE 7 0.0010
512 ADVERSE DRUG REACTION 94 0.0010
513 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
514 CORONARY ARTERY BYPASS 6 0.0010
515 DEEP VEIN THROMBOSIS 67 0.0010
516 BRAIN OEDEMA 13 0.0010
517 THROMBOCYTOPENIA 115 0.0010
518 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 73 0.0010
519 THERAPEUTIC RESPONSE SHORTENED 34 0.0010
520 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
521 DYSARTHRIA 38 0.0010
522 NEUROPATHY PERIPHERAL 96 0.0010
523 CHOLECYSTITIS 12 0.0010
524 BLOOD PRESSURE INCREASED 153 0.0010
525 ANAL INCONTINENCE 9 0.0010
526 GANGRENE 6 0.0010
527 CARDIAC DISORDER 93 0.0010
528 LOWER LIMB FRACTURE 19 0.0010
529 SKIN CANCER 21 0.0010
530 VENTRICULAR EXTRASYSTOLES 10 0.0010
531 APHASIA 29 0.0010
532 ARTERIOSCLEROSIS 9 0.0010
533 RECTAL HAEMORRHAGE 41 0.0010
534 LEUKAEMIA 9 0.0010
535 HALLUCINATION, VISUAL 20 0.0009
536 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
537 RENAL DISORDER 44 0.0009
538 INJECTION SITE IRRITATION 12 0.0009
539 STAPHYLOCOCCAL INFECTION 31 0.0009
540 MASS 13 0.0009
541 PEMPHIGOID 7 0.0009
542 PRODUCT STORAGE ERROR 81 0.0009
543 MUSCLE STRAIN 8 0.0009
544 HAEMORRHOIDS 18 0.0009
545 DRUG INEFFECTIVE 1215 0.0009
546 ACCIDENT 11 0.0009
547 NEOPLASM PROGRESSION 32 0.0009
548 HAEMORRHAGE 96 0.0009
549 ATRIAL FIBRILLATION 89 0.0009
550 INCORRECT PRODUCT STORAGE 12 0.0009
551 DEVICE RELATED INFECTION 14 0.0009
552 PARALYSIS 13 0.0009
553 UPPER LIMB FRACTURE 18 0.0009
554 INTESTINAL OBSTRUCTION 34 0.0009
555 BLOOD SODIUM DECREASED 17 0.0009
556 LUNG INFECTION 14 0.0009
557 LUNG DISORDER 44 0.0009
558 BASAL CELL CARCINOMA 14 0.0009
559 MALNUTRITION 10 0.0009
560 DYSPHONIA 52 0.0009
561 GENERALISED OEDEMA 11 0.0009
562 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
563 RENAL FAILURE 117 0.0009
564 LUNG NEOPLASM MALIGNANT 36 0.0009
565 FALL 291 0.0009
566 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 16 0.0009
567 PULMONARY MASS 13 0.0009
568 COLON CANCER 13 0.0009
569 BRAIN NEOPLASM 8 0.0009
570 DISCOMFORT 53 0.0009
571 LOCALISED INFECTION 21 0.0009
572 MYASTHENIA GRAVIS 7 0.0009
573 FRUSTRATION TOLERANCE DECREASED 7 0.0009
574 INJECTION SITE HAEMORRHAGE 69 0.0009
575 DIARRHOEA HAEMORRHAGIC 8 0.0009
576 KNEE ARTHROPLASTY 18 0.0009
577 PHOTOSENSITIVITY REACTION 14 0.0008
578 INTENTIONAL PRODUCT USE ISSUE 74 0.0008
579 DIVERTICULUM 6 0.0008
580 CARDIO-RESPIRATORY ARREST 35 0.0008
581 WRIST FRACTURE 10 0.0008
582 ACUTE RESPIRATORY FAILURE 16 0.0008
583 PANIC REACTION 6 0.0008
584 PRODUCT PREPARATION ERROR 17 0.0008
585 THERAPY NON-RESPONDER 37 0.0008
586 EAR PAIN 16 0.0008
587 ILLNESS 84 0.0008
588 ARTHROPOD BITE 6 0.0008
589 BACTERIAL INFECTION 15 0.0008
590 ARRHYTHMIA 38 0.0008
591 C-REACTIVE PROTEIN INCREASED 29 0.0008
592 TOXIC SKIN ERUPTION 8 0.0008
593 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
594 HYPOMAGNESAEMIA 11 0.0008
595 THROMBOSIS 63 0.0008
596 SEASONAL ALLERGY 11 0.0008
597 LIMB INJURY 21 0.0008
598 NO ADVERSE EVENT 140 0.0008
599 VASCULITIS 9 0.0008
600 CONDITION AGGRAVATED 234 0.0008
601 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
602 CIRCULATORY COLLAPSE 13 0.0008
603 BLOOD PRESSURE ABNORMAL 15 0.0008
604 GASTROENTERITIS 11 0.0008
605 PERSONALITY CHANGE 7 0.0008
606 VIRAL INFECTION 25 0.0008
607 HEPATIC ENCEPHALOPATHY 7 0.0007
608 BLOOD DISORDER 6 0.0007
609 CARDIOMYOPATHY 11 0.0007
610 NOCTURIA 9 0.0007
611 HYPOCALCAEMIA 14 0.0007
612 SPINAL DISORDER 7 0.0007
613 DEPRESSED MOOD 39 0.0007
614 DIARRHOEA 476 0.0007
615 HAEMATOTOXICITY 7 0.0007
616 NEUTROPHIL COUNT DECREASED 30 0.0007
617 BACK INJURY 8 0.0007
618 DIABETES MELLITUS 56 0.0007
619 POLYURIA 6 0.0007
620 SMALL INTESTINAL OBSTRUCTION 9 0.0007
621 BLOOD CREATINE PHOSPHOKINASE INCREASED 21 0.0007
622 RIB FRACTURE 15 0.0007
623 CYST 9 0.0007
624 ANAEMIA 137 0.0007
625 APHONIA 10 0.0007
626 ADVERSE EVENT 66 0.0007
627 DISORIENTATION 28 0.0007
628 BLADDER DISORDER 7 0.0007
629 ACUTE KIDNEY INJURY 107 0.0007
630 HEADACHE 438 0.0007
631 NEOPLASM 8 0.0007
632 HEAD INJURY 22 0.0007
633 FEBRILE NEUTROPENIA 46 0.0007
634 SCIATICA 11 0.0007
635 ORTHOSTATIC HYPOTENSION 12 0.0007
636 GASTRITIS 18 0.0007
637 EAR DISCOMFORT 7 0.0007
638 ASTHENIA 253 0.0007
639 HERNIA 13 0.0007
640 ROAD TRAFFIC ACCIDENT 28 0.0007
641 HEPATIC FAILURE 20 0.0007
642 URINARY TRACT INFECTION 113 0.0007
643 EXPIRED PRODUCT ADMINISTERED 22 0.0007
644 GASTROINTESTINAL CARCINOMA 6 0.0007
645 OPTIC NEURITIS 6 0.0007
646 ACUTE HEPATIC FAILURE 9 0.0007
647 SKIN ULCER 17 0.0007
648 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 34 0.0007
649 CARDIOMEGALY 8 0.0006
650 ANKLE FRACTURE 10 0.0006
651 SEPSIS 72 0.0006
652 OEDEMA 35 0.0006
653 SWELLING FACE 42 0.0006
654 SEPTIC SHOCK 28 0.0006
655 NEPHROPATHY 6 0.0006
656 HAEMATURIA 22 0.0006
657 EAR INFECTION 17 0.0006
658 NERVOUSNESS 33 0.0006
659 MALAISE 277 0.0006
660 BLOOD BILIRUBIN INCREASED 17 0.0006
661 BLOOD CREATININE INCREASED 41 0.0006
662 HERPES ZOSTER 36 0.0006
663 SNEEZING 14 0.0006
664 CARDIAC FAILURE CONGESTIVE 50 0.0006
665 HYPONATRAEMIA 35 0.0006
666 HEAD DISCOMFORT 11 0.0006
667 KIDNEY INFECTION 12 0.0006
668 MYOCARDITIS 7 0.0006
669 DYSPNOEA EXERTIONAL 23 0.0006
670 KNEE OPERATION 6 0.0006
671 BEDRIDDEN 8 0.0006
672 VERTIGO 37 0.0006
673 COLITIS 23 0.0006
674 BRAIN INJURY 6 0.0006
675 LOSS OF CONSCIOUSNESS 76 0.0006
676 SINUS CONGESTION 8 0.0006
677 ATAXIA 7 0.0006
678 INFLUENZA 65 0.0006
679 PULMONARY OEDEMA 26 0.0006
680 SYNCOPE 58 0.0006
681 THERAPEUTIC RESPONSE UNEXPECTED 26 0.0006
682 DRUG EFFECT INCOMPLETE 21 0.0006
683 PULMONARY HYPERTENSION 12 0.0006
684 DERMATITIS 12 0.0006
685 CHILLS 67 0.0006
686 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
687 GAIT INABILITY 19 0.0006
688 DECREASED APPETITE 132 0.0006
689 ABDOMINAL PAIN 132 0.0006
690 TENDON RUPTURE 7 0.0006
691 TINNITUS 26 0.0006
692 TOOTH EXTRACTION 7 0.0006
693 PNEUMONIA 182 0.0006
694 CORONARY ARTERY DISEASE 17 0.0006
695 PNEUMONIA ASPIRATION 14 0.0006
696 SUBDURAL HAEMATOMA 8 0.0006
697 FEAR 15 0.0006
698 IMPAIRED QUALITY OF LIFE 8 0.0006
699 BALANCE DISORDER 48 0.0006
700 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
701 OSTEOMYELITIS 10 0.0006
702 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
703 END STAGE RENAL DISEASE 10 0.0005
704 IMPAIRED HEALING 18 0.0005
705 BLOOD GLUCOSE FLUCTUATION 6 0.0005
706 DISEASE RECURRENCE 26 0.0005
707 HYPERKALAEMIA 19 0.0005
708 BRONCHITIS 40 0.0005
709 LEUKOPENIA 27 0.0005
710 SKIN HAEMORRHAGE 8 0.0005
711 URINARY RETENTION 18 0.0005
712 HEPATOTOXICITY 12 0.0005
713 HYPERSENSITIVITY 100 0.0005
714 AMNESIA 35 0.0005
715 PANCYTOPENIA 30 0.0005
716 NEPHROPATHY TOXIC 6 0.0005
717 HYPOAESTHESIA ORAL 8 0.0005
718 MUSCULOSKELETAL DISORDER 10 0.0005
719 HIP ARTHROPLASTY 8 0.0005
720 QUALITY OF LIFE DECREASED 7 0.0005
721 CARDIAC ARREST 43 0.0005
722 OSTEOARTHRITIS 22 0.0005
723 TACHYCARDIA 46 0.0005
724 LIMB DISCOMFORT 16 0.0005
725 POST PROCEDURAL HAEMORRHAGE 6 0.0005
726 EJECTION FRACTION DECREASED 8 0.0005
727 PNEUMONITIS 14 0.0005
728 EOSINOPHILIA 9 0.0005
729 CARDIOVASCULAR DISORDER 13 0.0005
730 PNEUMOTHORAX 8 0.0005
731 HAEMOPTYSIS 14 0.0005
732 COORDINATION ABNORMAL 7 0.0005
733 CONFUSIONAL STATE 81 0.0005
734 MALIGNANT NEOPLASM PROGRESSION 51 0.0005
735 CONTRAINDICATED PRODUCT ADMINISTERED 15 0.0005
736 BLOOD CHOLESTEROL INCREASED 23 0.0005
737 BACK DISORDER 8 0.0005
738 DYSURIA 18 0.0005
739 DRUG ADMINISTRATION ERROR 15 0.0005
740 ENCEPHALOPATHY 12 0.0005
741 PRODUCT USE IN UNAPPROVED INDICATION 121 0.0005
742 BLOOD GLUCOSE ABNORMAL 9 0.0005
743 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
744 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
745 DEHYDRATION 64 0.0005
746 SPEECH DISORDER 25 0.0005
747 HYPOKALAEMIA 22 0.0005
748 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
749 FOOT FRACTURE 9 0.0005
750 ABDOMINAL PAIN LOWER 12 0.0005
751 FACE OEDEMA 8 0.0005
752 CYSTITIS 15 0.0005
753 MUSCULOSKELETAL DISCOMFORT 8 0.0005
754 POOR QUALITY SLEEP 10 0.0005
755 PYREXIA 160 0.0005
756 DELIRIUM 16 0.0005
757 SKIN FISSURES 9 0.0005
758 TREATMENT FAILURE 38 0.0005
759 ALOPECIA 90 0.0005
760 BLOOD PRESSURE FLUCTUATION 11 0.0005
761 HEPATIC CANCER 11 0.0005
762 NEURALGIA 11 0.0005
763 RENAL IMPAIRMENT 38 0.0005
764 DRUG ERUPTION 8 0.0005
765 COGNITIVE DISORDER 21 0.0004
766 NECK PAIN 25 0.0004
767 RASH PAPULAR 10 0.0004
768 GOUT 8 0.0004
769 PELVIC PAIN 8 0.0004
770 HYPOTENSION 88 0.0004
771 SENSORY DISTURBANCE 7 0.0004
772 INCORRECT DOSE ADMINISTERED 99 0.0004
773 BRADYCARDIA 23 0.0004
774 WEIGHT DECREASED 121 0.0004
775 DIVERTICULITIS 12 0.0004
776 BLOOD POTASSIUM INCREASED 7 0.0004
777 HYPOPHAGIA 11 0.0004
778 HAEMATOMA 11 0.0004
779 GAIT DISTURBANCE 81 0.0004
780 RESPIRATORY TRACT INFECTION 11 0.0004
781 DIZZINESS 210 0.0004
782 PRODUCTIVE COUGH 20 0.0004
783 NERVOUS SYSTEM DISORDER 13 0.0004
784 PANCREATIC CARCINOMA 12 0.0004
785 FLUID RETENTION 21 0.0004
786 UNDERDOSE 30 0.0004
787 CHEST PAIN 76 0.0004
788 CHOKING 8 0.0004
789 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
790 PALLOR 11 0.0004
791 TREATMENT NONCOMPLIANCE 22 0.0004
792 LACTIC ACIDOSIS 13 0.0004
793 INFECTION 58 0.0004
794 SPINAL FRACTURE 8 0.0004
795 BLOOD POTASSIUM DECREASED 12 0.0004
796 LYMPHOCYTE COUNT DECREASED 7 0.0004
797 CONTUSION 38 0.0004
798 FEEDING DISORDER 8 0.0004
799 COUGH 110 0.0004
800 MOBILITY DECREASED 28 0.0004
801 FEMUR FRACTURE 12 0.0004
802 BLOOD GLUCOSE INCREASED 73 0.0004
803 OEDEMA PERIPHERAL 47 0.0004
804 RESPIRATORY FAILURE 28 0.0004
805 FEELING ABNORMAL 92 0.0004
806 PERIPHERAL SWELLING 59 0.0004
807 VOMITING 179 0.0004
808 MUSCULAR WEAKNESS 43 0.0004
809 MEDICATION ERROR 21 0.0004
810 CELLULITIS 19 0.0004
811 AGRANULOCYTOSIS 7 0.0004
812 COVID-19 66 0.0004
813 BLOOD GLUCOSE DECREASED 18 0.0004
814 FATIGUE 288 0.0004
815 CHRONIC KIDNEY DISEASE 28 0.0004
816 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
817 METASTASES TO BONE 6 0.0004
818 MEMORY IMPAIRMENT 50 0.0004
819 BLOOD PRESSURE DECREASED 24 0.0004
820 AGEUSIA 9 0.0004
821 RASH MACULO-PAPULAR 8 0.0004
822 ARTHRITIS 28 0.0004
823 GASTRIC CANCER 9 0.0004
824 DISABILITY 7 0.0004
825 DRUG EFFECT DECREASED 19 0.0004
826 NASOPHARYNGITIS 65 0.0004
827 PAIN 216 0.0004
828 HAEMOGLOBIN DECREASED 36 0.0004
829 ANAPHYLACTIC SHOCK 9 0.0003
830 NEPHROLITHIASIS 16 0.0003
831 PLATELET COUNT DECREASED 37 0.0003
832 MUSCLE TWITCHING 8 0.0003
833 PERICARDIAL EFFUSION 8 0.0003
834 PLEURAL EFFUSION 21 0.0003
835 MENTAL DISORDER 15 0.0003
836 DYSPNOEA 194 0.0003
837 HEART RATE DECREASED 12 0.0003
838 HYPOXIA 12 0.0003
839 NASAL CONGESTION 20 0.0003
840 INFLUENZA LIKE ILLNESS 28 0.0003
841 ASCITES 10 0.0003
842 ANGIOEDEMA 15 0.0003
843 ANXIETY 96 0.0003
844 DEVICE ISSUE 30 0.0003
845 RESPIRATORY DISORDER 10 0.0003
846 LIP SWELLING 11 0.0003
847 DEPRESSION 75 0.0003
848 ABDOMINAL PAIN UPPER 67 0.0003
849 PROCEDURAL PAIN 9 0.0003
850 PRURITUS GENERALISED 7 0.0003
851 FEELING COLD 9 0.0003
852 FAECES DISCOLOURED 7 0.0003
853 DEVICE DISLOCATION 14 0.0003
854 DRUG INTOLERANCE 31 0.0003
855 HYPOAESTHESIA 48 0.0003
856 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
857 MELAENA 7 0.0003
858 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
859 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
860 RASH MACULAR 11 0.0003
861 BACK PAIN 73 0.0003
862 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
863 AGITATION 23 0.0003
864 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
865 NAUSEA 246 0.0003
866 INTERSTITIAL LUNG DISEASE 15 0.0003
867 MUSCULOSKELETAL PAIN 16 0.0003
868 CRYING 11 0.0003
869 HAEMATOCRIT DECREASED 6 0.0003
870 ERYTHEMA 62 0.0003
871 GASTROOESOPHAGEAL REFLUX DISEASE 24 0.0003
872 TYPE 2 DIABETES MELLITUS 10 0.0003
873 SKIN EXFOLIATION 25 0.0003
874 RASH PRURITIC 16 0.0003
875 SEIZURE 34 0.0003
876 ARTHROPATHY 16 0.0003
877 WHITE BLOOD CELL COUNT DECREASED 31 0.0003
878 DYSPHAGIA 27 0.0003
879 ABASIA 7 0.0003
880 DYSGEUSIA 21 0.0003
881 INJECTION SITE ERYTHEMA 35 0.0003
882 HYPOTHYROIDISM 9 0.0003
883 JOINT INJURY 6 0.0003
884 HYPERSOMNIA 8 0.0003
885 LETHARGY 16 0.0003
886 FEELING HOT 17 0.0003
887 GASTROINTESTINAL HAEMORRHAGE 23 0.0003
888 HYPERGLYCAEMIA 10 0.0003
889 ASTHMA 31 0.0003
890 CHEST DISCOMFORT 28 0.0003
891 RESTLESSNESS 10 0.0003
892 SINUSITIS 28 0.0003
893 THERAPY CESSATION 14 0.0003
894 PAIN IN EXTREMITY 80 0.0003
895 URINARY INCONTINENCE 8 0.0003
896 SKIN DISORDER 9 0.0003
897 HYPOGLYCAEMIA 13 0.0003
898 HALLUCINATION 20 0.0003
899 PALPITATIONS 31 0.0003
900 OVERDOSE 57 0.0003
901 MIGRAINE 25 0.0003
902 OROPHARYNGEAL PAIN 24 0.0003
903 PRODUCT QUALITY ISSUE 35 0.0003
904 SWOLLEN TONGUE 8 0.0003
905 DYSPEPSIA 25 0.0003
906 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
907 ARTHRALGIA 105 0.0003
908 ACCIDENTAL EXPOSURE TO PRODUCT 26 0.0003
909 MUSCULOSKELETAL STIFFNESS 22 0.0003
910 OXYGEN SATURATION DECREASED 14 0.0002
911 TOXICITY TO VARIOUS AGENTS 42 0.0002
912 ECZEMA 13 0.0002
913 MENTAL IMPAIRMENT 6 0.0002
914 PAIN IN JAW 7 0.0002
915 FLATULENCE 14 0.0002
916 DEVICE BREAKAGE 10 0.0002
917 SWELLING 23 0.0002
918 PRURITUS 94 0.0002
919 CHOLELITHIASIS 8 0.0002
920 OSTEOPOROSIS 10 0.0002
921 CONSTIPATION 53 0.0002
922 DEVICE DIFFICULT TO USE 16 0.0002
923 DISTURBANCE IN ATTENTION 13 0.0002
924 THERAPY INTERRUPTED 17 0.0002
925 HAEMATEMESIS 6 0.0002
926 OESOPHAGEAL CARCINOMA 7 0.0002
927 ANAPHYLACTIC REACTION 13 0.0002
928 DRY MOUTH 19 0.0002
929 RASH 101 0.0002
930 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
931 LYMPHADENOPATHY 8 0.0002
932 INJECTION SITE SWELLING 17 0.0002
933 PANIC ATTACK 8 0.0002
934 OSTEONECROSIS 7 0.0002
935 GASTRIC DISORDER 7 0.0002
936 INJECTION SITE REACTION 14 0.0002
937 URTICARIA 34 0.0002
938 PROSTATE CANCER 16 0.0002
939 EPILEPSY 6 0.0002
940 SKIN DISCOLOURATION 9 0.0002
941 MYALGIA 33 0.0002
942 HYPERHIDROSIS 25 0.0002
943 SOMNOLENCE 39 0.0002
944 ABDOMINAL DISTENSION 20 0.0002
945 INSOMNIA 51 0.0002
946 ACCIDENTAL OVERDOSE 7 0.0002
947 GASTROINTESTINAL DISORDER 17 0.0002
948 RENAL CANCER 9 0.0002
949 RASH ERYTHEMATOUS 9 0.0002
950 HOT FLUSH 14 0.0002
951 BURNING SENSATION 13 0.0002
952 ABDOMINAL DISCOMFORT 31 0.0002
953 HEART RATE INCREASED 18 0.0002
954 TREMOR 30 0.0002
955 BLISTER 10 0.0002
956 ABORTION SPONTANEOUS 7 0.0002
957 JOINT SWELLING 21 0.0002
958 BONE PAIN 10 0.0002
959 BLADDER CANCER 10 0.0002
960 POLLAKIURIA 7 0.0002
961 DRUG INTERACTION 26 0.0002
962 HAEMATOCHEZIA 9 0.0002
963 PARAESTHESIA 25 0.0002
964 SLEEP DISORDER 11 0.0002
965 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
966 PANCREATITIS 8 0.0002
967 DRY SKIN 20 0.0001
968 DYSKINESIA 6 0.0001
969 COMA 7 0.0001
970 SUICIDAL IDEATION 13 0.0001
971 EMOTIONAL DISTRESS 17 0.0001
972 INJECTION SITE BRUISING 11 0.0001
973 LIVER DISORDER 6 0.0001
974 WEIGHT INCREASED 30 0.0001
975 IRRITABILITY 8 0.0001
976 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
977 MUSCLE SPASMS 24 0.0001
978 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
979 BREAST CANCER 12 0.0001
980 PSORIASIS 16 0.0001
981 AGGRESSION 6 0.0001
982 WHEEZING 7 0.0001
983 INTENTIONAL PRODUCT MISUSE 10 0.0001
984 INJURY 8 0.0001
985 RHEUMATOID ARTHRITIS 12 0.0001
986 CONVULSION 6 0.0001
987 INJECTION SITE PRURITUS 6 0.0001
988 COMPLETED SUICIDE 7 0.0001
989 DRUG DOSE OMISSION BY DEVICE 6 0.0001
990 FLUSHING 7 0.0001